| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/02/2011 | US20110129542 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 06/02/2011 | US20110129541 Suspension delivery system for the sustained and controlled local release of pharmaceuticals |
| 06/02/2011 | US20110129539 Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin |
| 06/02/2011 | US20110129538 Process for preparing orally administered dabigatran formulations |
| 06/02/2011 | US20110129537 Functionalized metal-coated energy converting nanoparticles, methods for production thereof and methods for use |
| 06/02/2011 | US20110129535 Transdermal testosterone device and delivery |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129533 Porous drug matrices and methods of manufacture thereof |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129528 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 06/02/2011 | US20110129527 Rab3b for the treatment and prevention of parkinson's disease |
| 06/02/2011 | US20110129524 Therapeutic agent for cancer, and method for treatment of cancer |
| 06/02/2011 | US20110129523 Liposomally Encapsulated Reduced Glutathione, including with Other Pharmacologic Preparation, Capable of Administration as an Oral, Topical, Intraoral or Transmucosal, Prepartion, for Reversal and Prevention of Oxidation of Cholesterol and of Low Density Lipoprotein |
| 06/02/2011 | US20110129521 Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
| 06/02/2011 | US20110129519 Modafinil-Based Treatment For Premature Ejaculation |
| 06/02/2011 | US20110129517 Tablettable chewing gums |
| 06/02/2011 | US20110129516 Ocular drug delivery devices |
| 06/02/2011 | US20110129515 Devices and Methods for Nerve Regeneration |
| 06/02/2011 | US20110129513 Compositions and methods for coating medical implants |
| 06/02/2011 | US20110129512 Antimicrobial Releasing Polymers |
| 06/02/2011 | US20110129507 Controlled release formulations exhibiting an ascending rate of release |
| 06/02/2011 | US20110129504 Composition for controlling lipase catalyzed reactions |
| 06/02/2011 | US20110129502 Immunogenic Constructs |
| 06/02/2011 | US20110129490 Modulation of production of retroviruses by apobec4 |
| 06/02/2011 | US20110129485 Modified Galectin-2 and Uses Thereof |
| 06/02/2011 | US20110129476 Mzb1, a novel b cell factor, and uses thereof |
| 06/02/2011 | US20110129472 Methods for controlling vasculogenesis |
| 06/02/2011 | US20110129469 Methods for treating fatty liver disease |
| 06/02/2011 | US20110129467 Therapeutic combination comprising an aurora kinase inhibitor and antiproliferative agents |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129461 Mat II Beta Subunit RNAi and Therapeutic Methods Using Same |
| 06/02/2011 | US20110129455 Inhibitors of akt activity |
| 06/02/2011 | US20110129453 Topical skin composition and method for moisturizing the skin |
| 06/02/2011 | US20110129450 Method of promoting neurogenesis by modulating secretase activities |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/02/2011 | US20110129445 Combinations comprising methotrexate and dhodh inhibitors |
| 06/02/2011 | US20110129443 Macrocyclic serine protease inhibitors |
| 06/02/2011 | US20110129442 Lipoic acid pellet composition |
| 06/02/2011 | US20110129440 Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129437 Platelet adhesion-resistant material |
| 06/02/2011 | US20110129436 Polyglycerol sebecate peritoneal adhesion prevention barrier |
| 06/02/2011 | US20110129435 Hydrogen peroxide-based skin disinfectant |
| 06/02/2011 | US20110129434 Moisturizing agent |
| 06/02/2011 | US20110129433 Compositions and Methods for Treating or Preventing Gastrointestinal Disorders and GERD-Related Respiratory Disorders |
| 06/02/2011 | US20110129432 L-menthyl-n-(2-hydroxyphenyl)carbamate |
| 06/02/2011 | US20110129426 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia |
| 06/02/2011 | US20110129422 Viscous Terpolymers as Drug Delivery Platform |
| 06/02/2011 | US20110129421 Matrix metalloprotease targeting nucleic acids |
| 06/02/2011 | US20110126767 Methods and compositions for increasing the hatchability of hatchery eggs |
| 06/02/2011 | US20110126501 Composition for prevention of influenza viral infection comprising tannic acid, air filter comprising the same and air cleaning device comprising the filter |
| 06/01/2011 | EP2327789A1 Novel compound signamycin, method for production thereof, and use thereof |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327783A1 Pharmaceutical composition comprising miRNA-100 and its use in the modulation of blood vessel growth |
| 06/01/2011 | EP2327781A1 Micro-RNA and tissue repair |
| 06/01/2011 | EP2327717A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327716A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327715A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327708A2 Purification method for adefovir dipivoxil |
| 06/01/2011 | EP2327705A1 Podophyllotoxins as antiproliferative agents |
| 06/01/2011 | EP2327704A1 Ring-fused azole derivative having pi3k-inhibiting activity |
| 06/01/2011 | EP2327703A1 Ligand with a broad spectrum of pharmacological activity, a pharmaceutical composition, a medicinal agent and a method of treatment |
| 06/01/2011 | EP2327702A1 Mitotic kinesin inhibitor |
| 06/01/2011 | EP2327701A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/01/2011 | EP2327699A1 Glucocorticoid receptor agonist comprising novel 1,2,3,4-tetrahydroquinoxaline derivative containing phenyl group having sulfonic acid ester structure introduced therein as substituent |
| 06/01/2011 | EP2327698A1 Process for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate |
| 06/01/2011 | EP2327697A1 The salts of n-ý4-(1-cyanocyclopentyl)phenyl¨-2-(4-pyridyl methyl)amino-3-pyridinecarboxamide |
| 06/01/2011 | EP2327693A1 Indoles and their therapeutic use |
| 06/01/2011 | EP2327692A1 1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors |
| 06/01/2011 | EP2327690A1 Tricyclic compound |
| 06/01/2011 | EP2327687A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/01/2011 | EP2327686A2 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327411A1 Arabinogalactan as immune enhancer |
| 06/01/2011 | EP2327410A1 Avermectins and milbemycins for the treatment of flavivirus infections |
| 06/01/2011 | EP2327409A1 Tetracycline compound having target therapeutic activities |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2327407A1 Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
| 06/01/2011 | EP2327406A1 Stabilized pharmaceutical composition |
| 06/01/2011 | EP2327405A1 Pharmaceutical composition comprising cinchonains 1a and 1b, process for preparing an epimeric mixture of cinchonains 1a and 1b, use and method for reverting/combating ventricular fibrillation |
| 06/01/2011 | EP2327404A1 Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
| 06/01/2011 | EP2327403A2 Pharmaceutical combinations of at least two bronchodilators |
| 06/01/2011 | EP2327402A2 Composition containing 4-o-methylhonokiol for treating or preventing amyloid- related diseases |
| 06/01/2011 | EP2327401A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP2327400A2 Retinoid Replacements and Opsin Agonists and Methods for the Use Thereof |
| 06/01/2011 | EP2327399A1 Treatment of hypertension |
| 06/01/2011 | EP2327398A2 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 06/01/2011 | EP2327394A1 Liquid pharmaceutical composition |
| 06/01/2011 | EP2326719A1 Gene silencing |
| 06/01/2011 | EP2326655A1 Aminophosphinic derivatives that can be used in the treatment of pain |
| 06/01/2011 | EP2326653A1 New (poly)aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents |
| 06/01/2011 | EP2326652A1 Nitro derivatives of furasemide and their use as diuretics |
| 06/01/2011 | EP2326651A1 Buprenorphine analogs |
| 06/01/2011 | EP2326650A2 Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp) |
| 06/01/2011 | EP2326649A1 Novel pyrrolo ý2,3-a¨carbazoles and use thereof as pim kinase inhibitors |
| 06/01/2011 | EP2326647A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoioý4,5- c¨pyridinyl)purine and purinone derivatives for immunosuppression |
| 06/01/2011 | EP2326646A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/01/2011 | EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |